Doximity Inc. Class A (DOCS)
NYSE: DOCSTechnologyEDP ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
DOCS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.13B
- P/E (TTM)
- 39.90
- Forward P/E
- 18.53
- EPS (TTM)
- $0.72
- Dividend yield
- None
- 52-week range
- 17.15 – 51.85
- Day range
- 28.55 – 29.86
- Volume / Avg
- 2.38M / 2.74M
- Beta
- —
- Shares outstanding
- 127.52M
52-week range
DOCS stock today
Doximity (DOCS) closed at $28.73 on Nov 20, down 2.97% (-$0.88), versus the S&P 500's 3.70% decline. Shares are 44.6% below their 52-week high of $51.85, set on Nov 28, 2025 and 67.5% above the 52-week low of $17.15, in the middle of the past year's range. DOCS is down 35.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 43.0%.
At 39.9x trailing earnings, Doximity trades above the peer-group median of 16.7x. Its forward P/E of 18.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Doximity
Company profileDoximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems.
- Sector
- Technology
- Industry
- EDP Services
- CEO
- Mr. Jeffrey A. Tangney
- Headquarters
- San Francisco, CA
- Employees
- 880
- IPO year
- 2021
- Website
- doximity.com
Financial highlights
Full financialsIn fiscal 2026, Doximity generated $644.9 million in revenue, up 13.1% from fiscal 2025, its 6th consecutive year of revenue growth. Net income was $196.1 million (-12.2% year over year), for a net margin of 30.4% versus a median of 31.0% in the prior 5 years. Gross margin was 89.1% (down from 90.2%) and operating margin 33.3%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $644.86M | $570.40M | $475.42M | $419.05M | $343.55M |
| Growth | +13.05% | +19.98% | +13.45% | +21.98% | +66.05% |
| Net income | $196.05M | $223.19M | $147.58M | $112.82M | $154.78M |
| EPS (diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 |
Analyst forecast
ForecastConsensus (21 analysts)
hold
Avg. price target
$31.50+9.64%
- Strong buy 5
- Buy 3
- Hold 11
- Sell 1
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.18 vs $0.19
- Surprise
- -5.26%
DOCS news
All DOCS news- Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCSPR Newswire
- DOCS Expands Clinical AI Tools Across Three Major U.S. Health SystemsNasdaqDOCS, ISRG, WST, GKOS
- DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS LawPR Newswire
- What's Next for Doximity, Inc. Shareholders After 23% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff DeadlinePR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCSPR Newswire
- SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Doximity, Inc. Lawsuit - DOCSPR Newswire
- What Does Doximity, Inc.'s 23% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outlines Securities Fraud Class Action Lead Plaintiff DeadlinePR Newswire
- Levi & Korsinsky Reminds Doximity, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - DOCSPR Newswire
Doximity peers
Technology sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| WAYWaystar Holding Corp. | 26.52 | -2.10% | $5.10B | vs DOCS |
| PSNParsons Corporation | 50.05 | -3.66% | $5.28B | vs DOCS |
| OTEXOpen Text Corporation | 22.63 | +1.39% | $5.47B | vs DOCS |
| RNGRingCentral Inc. Class A | 66.61 | -0.97% | $5.62B | vs DOCS |
| PEGAPegasystems Inc. | 27.25 | -2.92% | $4.46B | vs DOCS |
| DOXAmdocs Limited | 41.18 | +1.68% | $4.30B | vs DOCS |
| SAICScience Applications International Corporation | 142.27 | -0.74% | $5.96B | vs DOCS |
| BILIBilibili Inc. ADR | 10.60 | -4.16% | $4.24B | vs DOCS |
Indexes, lists and sector
Appears in lists
Largest Technology stocks
Doximity stock FAQ
What is Doximity's stock price today?
DOCS last traded at $28.73 as of Nov 20, 4:00 PM EST, down 2.97% on the day. Prices are delayed at least 15 minutes.
What is DOCS's P/E ratio?
DOCS trades at a trailing P/E ratio of 39.90 and a forward P/E of 18.53, compared with a median of 16.7 for its closest peers.
Who is Doximity's CEO?
Mr. Jeffrey A. Tangney is the chief executive officer of Doximity Inc. Class A, which has about 880 employees.
What is the DOCS 52-week high?
The 52-week high for DOCS is $51.85 and the 52-week low is $17.15. The stock is currently 44.6% below its high.